0000950170-24-018724.txt : 20240222 0000950170-24-018724.hdr.sgml : 20240222 20240222160007 ACCESSION NUMBER: 0000950170-24-018724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levisetti Matteo CENTRAL INDEX KEY: 0001962444 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 24664564 MAIL ADDRESS: STREET 1: C/O CUE BIOPHARMA, INC. STREET 2: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2024-02-20 false 0001645460 Cue Biopharma, Inc. CUE 0001962444 Levisetti Matteo C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 false true false false Chief Medical Officer false Stock Option (right to buy) 3.36 2024-02-20 4 A false 25000 0.0 A 2033-01-16 Common Stock 25000 25000 D On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full. /s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact 2024-02-22